USPTO trademark

PRIME CLEARVIEW

Under examinationUSPTOWord markClass 35Class 36Class 42Class 44

"PRIME CLEARVIEW" is a word mark owned by Prime Therapeutics LLC, filed at the USPTO on April 1, 2026. It is under examination and covers classes 35, 36, 42 and 44.

View Prime Therapeutics LLC portfolioGet this data via the API
Official USPTO record
PRIME CLEARVIEW trademark as filed
As filed with the USPTO
Status
Under examination
Since August 27, 2026
Filed
April 1, 2026
Registered
Not yet
Expires
Not recorded
Application no.
99738663
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
4 classes
Ownership

Who owns PRIME CLEARVIEW

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Prime Therapeutics LLC

Eagan, United States

45 trademarks in the portfolioView company

Representative

Felicia J. Boyd

Norton Rose Fulbright US LLP

Goods and services

What the mark covers

The products and services PRIME CLEARVIEW is filed for, grouped by Nice class.

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notification of letter of suspension e-mailed
  2. Letter of suspension e-mailed
  3. Suspension letter written
  4. Assigned to examiner
  5. New application office supplied data entered
  6. Application filing receipt mailed
  7. New application entered
FAQ

About PRIME CLEARVIEW

Who owns the trademark "PRIME CLEARVIEW"?

The USPTO trademark "PRIME CLEARVIEW" (application 99738663) is owned by Prime Therapeutics LLC.

What is the status of "PRIME CLEARVIEW"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull PRIME CLEARVIEW and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d5617-98e0-7348-a2c5-ec44d0bd839c
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d5617-98e0-7348-a2c5-ec44d0bd839c",
  "object": "trademark",
  "mark_text": "PRIME CLEARVIEW",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "99738663",
  "filing_date": "2026-04-01",
  "nice_classes": [
    35,
    36,
    42,
    44
  ],
  "owners": [
    {
      "name": "Prime Therapeutics LLC",
      "entity_id": "ent_019eb6fe-75bc-7498-b91a-6bffe9e5b38d"
    }
  ]
}